CHICAGO, Oct 29 (Reuters) - Beckman Coulter, a maker of biomedical testing instrument systems, reported lower quarterly net earnings on Thursday because of its acquisition of Olympus.
Third-quarter earnings were $1.5 million, or 2 cents per share, in the third quarter, compared with $24.1 million, or 37 cents per share, in the year-ago period.
Adjusted earnings per share were 85 cents. That was a penny above analysts' average forecast of 84 cents per share, according to Thomson Reuters I/B/E/S.
Revenue rose to $822.8 million in the quarter from $758.8 million a year earlier.

(Reporting by Debra Sherman; Editing by Gary Hill) Keywords: BECKMAN/EARNS (debra.sherman@thomsonreuters.com; + 312 408 8134; Reuters Messaging: debra.sherman.reuters.com@reuters.net)

COPYRIGHT

Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.